Third Circuit Expands Actavis Ruling to Non-Cash Settlements
The U.S. Court of Appeals for the Third Circuit has ruled that the Supreme Court's 2013 ruling in FTC v. Actavis, which allowed antitrust suits over reverse cash payments by drug manufacturers to keep generic versions of their products off the market, also applies to non-cash settlements of such disputes.
June 26, 2015 at 07:20 AM
6 minute read
The original version of this story was published on New Jersey Law Journal
The U.S. Court of Appeals for the Third Circuit has ruled that the U.S. Supreme Court's 2013 ruling in FTC v. Actavis, which allowed antitrust suits over reverse cash payments by drug manufacturers to keep generic versions of their products off the market, also applies to noncash settlements of such disputes.
The Third Circuit reversed a ruling by U.S. District Judge William Walls of the District of New Jersey, who dismissed an antitrust class action against drugmakers GlaxoSmithKline and Teva Pharmaceuticals over their agreement to postpone a generic version of Lamictal, which is used to treat epilepsy and bipolar disorder. The appeals court, ruling in a suit on behalf of direct purchasers of the drug, said the holding in Actavis was not limited to reverse payments of cash. According to the court, a so-called “no-AG (authorized generic) agreement,” when it represents a large transfer of value from the patent holder to the generic company, may be subject to antitrust scrutiny.
A no-AG agreement is likely to be “as harmful” as a reverse payment of cash, the Third Circuit said. By using a no-AG agreement to induce a generic company to abandon its patent fight, a drug company eliminates the chance of defeating a questionable patent, and along with it the prospects of a more competitive market, the Third Circuit said.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllMcCarter & English Acquires Connecticut IP Boutique Harrington & Smith
Big Law Making Top IP Partner Hires as 'Demand Far Outweighs Supply' of First-Chair Patent Litigators
Clients 'No Longer Need to Be Referred Out': Womble and Lewis Roca Eye Merger Benefits
'Stereophonic' Accused of Copyright Infringement From Fleetwood Mac 'Rumours' Producer
4 minute readTrending Stories
- 1A&O Shearman Adopts 3-Level Lockstep Pay Model Amid Shift to All-Equity Partnership
- 2A RICO Surge Is Underway: Here's How the Allstate Push Might Play Out
- 3The Law Firm Disrupted: Playing the Talent Game to Win
- 4Data-Driven Legal Strategies
- 5Preparing Your Law Firm for 2025: Smart Ways to Embrace AI & Other Technologies
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250